X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (4) 4
european-organization (2) 2
humans (2) 2
index medicus (2) 2
male (2) 2
phase-iii trial (2) 2
prostate cancer (2) 2
1st-line treatment (1) 1
activation (1) 1
androgen blockade (1) 1
angiogenesis (1) 1
antibodies, monoclonal - immunology (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antibody immunotherapy (1) 1
antineoplastic agents - immunology (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic agents, hormonal - therapeutic use (1) 1
article (1) 1
b7-h1 antigen - immunology (1) 1
bacillus-calmette-guerin (1) 1
binding sites (1) 1
biomarkers (1) 1
bladder cancer (1) 1
cancer (1) 1
cancer therapies (1) 1
carcinoma, renal cell - immunology (1) 1
carcinoma, renal cell - therapy (1) 1
care and treatment (1) 1
cell adhesion & migration (1) 1
cell bladder-carcinoma (1) 1
chemokine cxcl10 - immunology (1) 1
chemokine cxcl9 - immunology (1) 1
chemotherapy (1) 1
clinical trials (1) 1
clinical trials as topic (1) 1
clinical-trials (1) 1
comparing gemcitabine (1) 1
confidence (1) 1
cooperative group (1) 1
cyproterone-acetate (1) 1
dose estramustine phosphate (1) 1
double-blind (1) 1
drug resistance, neoplasm (1) 1
endothelial growth-factor (1) 1
eortc-gu group (1) 1
everolimus (1) 1
everolimus - immunology (1) 1
everolimus - therapeutic use (1) 1
expression (1) 1
factor receptor-2 (1) 1
female (1) 1
final analysis (1) 1
gu cancer-other (1) 1
hematology (1) 1
hematology, oncology and palliative medicine (1) 1
immune cells (1) 1
immune responses to cancer (1) 1
immunologic factors - immunology (1) 1
immunologic factors - therapeutic use (1) 1
immunomodulation (1) 1
immunotherapy (1) 1
interferon-gamma - immunology (1) 1
kidney cancer (1) 1
kidney neoplasms - immunology (1) 1
kidney neoplasms - therapy (1) 1
kinases (1) 1
long-term safety (1) 1
lymphocytes - drug effects (1) 1
lymphocytes - immunology (1) 1
medical prognosis (1) 1
medical-research-council (1) 1
metastasis (1) 1
metastatic prostate-cancer (1) 1
middle aged (1) 1
mitomycin-c (1) 1
monoclonal antibody (1) 1
monoclonal-antibody (1) 1
multicenter studies as topic (1) 1
nivolumab (1) 1
nuclear radiation (1) 1
oncology, experimental (1) 1
open-label (1) 1
pd-1 blockade (1) 1
pd-1 inhibition (1) 1
permeability (1) 1
phase i-iii trials-gu cancer-other (1) 1
phase ii (1) 1
phase iii (1) 1
prognostic-factors (1) 1
prospective studies (1) 1
prostatic neoplasms - drug therapy (1) 1
prostatic neoplasms - pathology (1) 1
quality-of-life (1) 1
radiation (1) 1
ramucirumab (1) 1
randomized clinical trials (1) 1
randomized clinical-trials (1) 1
randomized phase-ii (1) 1
renal cell carcinoma (1) 1
research (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Cancer Research, ISSN 1078-0432, 11/2016, Volume 22, Issue 22, pp. 5461 - 5471
Journal Article
Future Oncology, ISSN 1479-6694, 05/2018, Volume 14, Issue 11, pp. 1049 - 1061
Advanced urothelial cancer (UC) is a lethal disease despite current advances in systemic therapy, including platinum chemotherapy combinations and immune... 
targeted therapy | urothelial carcinoma | ramucirumab | angiogenesis | bladder cancer | VEGFR | monoclonal antibody | 1ST-LINE TREATMENT | MONOCLONAL-ANTIBODY | OPEN-LABEL | COMPARING GEMCITABINE | FACTOR RECEPTOR-2 | WEEKLY PACLITAXEL | ONCOLOGY | RANDOMIZED PHASE-II | TRANSITIONAL-CELL CARCINOMA | DOUBLE-BLIND | ENDOTHELIAL GROWTH-FACTOR
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.